NasdaqCM - Nasdaq Real Time Price • USD
Kazia Therapeutics Limited (KZIA)
As of 12:32 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 60k | 510k |
| Low Estimate | -- | -- | 60k | 510k |
| High Estimate | -- | -- | 60k | 510k |
| Year Ago Sales | -- | -- | -- | 60k |
| Sales Growth (year/est) | -- | -- | -- | 750.00% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | -0.04 | -0.03 |
| 30 Days Ago | 0 | 0 | -0.04 | -0.03 |
| 60 Days Ago | 0 | 0 | -0.04 | -0.03 |
| 90 Days Ago | 0 | 0 | -0.04 | -0.03 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | KZIA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 12.10% |
| Current Year | -- | -- | -- | 4.40% |
| Next Year | -- | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | HC Wainwright & Co.: Neutral to Buy | 4/11/2023 |
| Downgrade | Maxim Group: Buy to Hold | 8/2/2022 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 8/2/2022 |
| Initiated | Maxim Group: Buy | 10/14/2021 |
| Initiated | HC Wainwright & Co.: Buy | 1/5/2021 |
Related Tickers
CNSP CNS Pharmaceuticals, Inc.
0.2145
+2.63%
TCON TRACON Pharmaceuticals, Inc.
1.7899
-0.01%
NRXP NRx Pharmaceuticals, Inc.
3.2992
+5.07%
CNTB Connect Biopharma Holdings Limited
1.3600
+0.76%
EYEN Eyenovia, Inc.
0.6800
-4.35%
ATHE Alterity Therapeutics Limited
2.5263
+10.32%
OVID Ovid Therapeutics Inc.
3.0600
+2.35%
KTRA Kintara Therapeutics, Inc.
0.1438
-9.00%
ONVO Organovo Holdings, Inc.
0.9929
+0.48%
GLMD Galmed Pharmaceuticals Ltd.
0.3869
-0.31%